Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Janet maker

Janet maker

University of California, USA

Sheng-Miauh Huang

Sheng-Miauh Huang

Mackay Medical College Taiwan

Dr Nikhil Garg

Dr Nikhil Garg

Gujarat Cancer and Research Institute India

shadia al bahlani

shadia al bahlani

Sultan Qaboos University, Oman

Lai Oi Ling

Lai Oi Ling

University of the West of England, England

Kuei-Hui Chu

Kuei-Hui Chu

National Yang-Ming University, Taiwan

selma sakhri

selma sakhri

Maherzy School of Medicine, Algeria

Amy Hong Zhang

Amy Hong Zhang

University of Texas, USA

Breast Cancer Summit 2017

About Conference


ConferenceSeries Ltd invites all the participants from all over the world to attend "4th World Congress on Breast Cancer and Women’s Health" during May 08-10, 2017 in Holiday Inn Atrium, Singapore. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The theme for the conference this year is To Expose the Advances in Breast Cancer Research” promises an outstanding scientific program featuring many well-known and thought provoking speakers.

Breast Cancer Summit 2017 aims to provide optimal health and healthcare to adolescent girls and women, with focus on the prevention, diagnosis and management of Fertility Disorders and diseases of Gynaecological and Breast Origin, as well as related Genetics, Pathophysiology, Epidemiology, Clinical Reports etc. The shift in medicine and healthcare from management of disease towards promoting wellness is a keystone in addressing the upstream caused of disease and ensuring that all women have equal opportunities.  Therefore it is very appropriate to bring together the experts in the field from all over the globe as we share experiences and knowledge and work together on ensuring a just reproductive health to all women.

ConferenceSeries Ltd organizes a conference series of 3000+ Global Events inclusive of 1000+ Conferences, 1000+ Upcoming and Previous Symposiums and 1000+ Workshops in USA, Europe, Middle East & Asiapacific with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about Women’s Health and its advances; this is your best opportunity to reach the largest assemblage of participants from the Women’s Health community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the breast cancer treatment and diagnosis, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in women’s health, breast cancer, gynaecological issues, pregnancy, Woman Psychology, women disorders are hallmarks of this conference.

Target Audience:

  • Cancer research Students, Scientists
  • Cancer Researchers
  • Cancer research Faculty
  • Medical Colleges
  • Cancer Associations and Societies
  • Oncologists
  • Radiologists
  • Chemotherapists
  • Pathologists
  • Physicians
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Pharmaceutical Companies
  • Diagnostics Companies

Importance & Scope:     

Women's Health refers to physical and mental well-being of woman. Some of them relate to genetic issues such as Diabetes, Thyroid, etc. while others may include serious gynaecological issues caused by hormonal or physical imbalance specific to, or most notable in females. Breast cancer is the most common cause of death in women. Research on breast cancer is rapidly progressing, yet the systematic application of current knowledge to improve patient care remains a formidable challenge. Breast Cancer Summit  aims to provide optimal health and healthcare to adolescent girls and women, with focus on the prevention, diagnosis and management of Fertility Disorders and diseases of Gynaecological and Breast Origin, as well as related Genetics, Pathophysiology, Epidemiology, Clinical Reports etc.

Breast Cancer Summit  is designed to offer comprehensive range of sessions that includes; Women’s Health, mental health, breaking systems in the diagnosis of breast cancer are Mammograms, breast cancer screenings and genomic tests; novel discoveries in breast treatments and latest developments in patient care. The main objective of conference is shift in medicine and healthcare from management of disease towards promoting wellness is a keystone in addressing the upstream caused of disease and ensuring that all women have equal opportunities.  Therefore it is very appropriate to bring together the experts in the field from all over the globe as we share experiences and knowledge and work together on ensuring a just reproductive health to all women.

Sessions & Tracks

Conference LLC invites all the participants from all over the world to attend “4th World Congress on Breast Cancer and Women’s Health during May 08-10, 2017 in Singapore City, Singapore.  which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The theme for the conference this year is To Expose the Advances in Breast Cancer Research” promises an outstanding scientific program featuring many well-known and thought provoking speakers.

Breast Cancer Summit 2017 aims to provide optimal health and healthcare to adolescent girls and women, with focus on the prevention, diagnosis and management of Fertility Disorders and diseases of Gynaecological and Breast Origin, as well as related Genetics, Pathophysiology, Epidemiology, Clinical Reports etc. 

Track 1: Breast Cancer-Present Perspective

At least one in nine women develops breast cancer at some stage in their life. About 48,000 cases occur in the United Kingdom every year. Mostly develops in women over the age of 50 but younger women are also sometimes affected. Breast cancer can also develop in men, but this is rare. Breast cancer develops from a cancerous cell which develops in the lining of a mammary duct or a lobule in one of the breasts. It follows the classic progression though it often becomes systemic or widespread in the early onset of the disease. During this period, the cancer may metastasize, or spread through lymphatic’s or blood stream to areas elsewhere in the body. If breast cancer spreads to vital organs of the body, its presence will compromise the function of those organs. Fatal death is the result of extreme case of vital organ function.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 2: Types of breast cancer

Breast cancer can begin in different areas of the breast — the ducts, the lobules, or in some cases, the tissue in between. In this section, you can learn about the different types of breast cancer, including non-invasive, invasive, recurrent, and metastatic breast cancers.

Relevant conferences:

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 3: Causes of Breast Cancer

Experts are not definitively sure what causes breast cancer. It is hard to say why one person develops the disease while another does not. We know that some risk factors can impact on a woman's likelihood of developing breast cancer. These are: The older a woman gets, the higher is her risk of developing breast cancer; age is a risk factor. Over 80% of all female breast cancers occur among women aged 50+ years (after the menopause). Women who carry the BRCA1 and BRCA2 genes have a considerably higher risk of developing breast and/or ovarian cancer. These genes can be inherited. The Mayo Clinic says that if a woman wants to drink, she should not exceed one alcoholic beverage per day Undergoing X-rays and CT scans may raise a woman's risk of developing breast cancer slightly. Scientists at the Memorial Sloan-Kettering Cancer Centre found that women who had been treated with radiation to the chest for a childhood cancer have a higher risk of developing breast cancer both forms, combined and oestrogen only HRT therapies may increase a woman's risk of developing breast cancer slightly. Combined HRT causes a higher risk. French researchers found that women who worked at night prior to a first pregnancy had a higher risk of eventually developing breast cancer.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 4: Epidemiology

The epidemiology of Breast cancer is the study of the factors affecting cancer, as a way to infer possible trends and causes.  Breast cancer is the most commonly diagnosed cancer among women, with approximately 182,000 women diagnosed with breast cancer annually in the United States, accounting for approximately 26% of all incident cancers among women. Each year, 40,000 women die of breast cancer, making it the second-leading cause of cancer deaths among American women after lung cancer. The lifetime risk of dying of breast cancer is approximately 3.4%. Breast cancer comprises 22.9% of invasive cancers in women and 16% of all female cancers. In 2008, breast cancer caused 458,503 deaths worldwide, 13.7% of cancer deaths in women and 6.0% of all cancer deaths for men and women together. The number of cases worldwide has significantly increased since the 1970s, a phenomenon partly attributed to the modern lifestyles.

Relevant conferences:

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 5: Diagnosis

Breast cancers are easy to diagnose by microscopic analysis of a sample or biopsy of the affected area of the breast. Also, there are types of breast cancer that require specialized lab exams. The two most commonly used screening methods, physical examination of the breasts by a healthcare provider and mammography, can offer an approximate likelihood that a lump is cancer, and may also detect some other lesions, such as a simple cyst. When these examinations are inconclusive, a healthcare provider can remove a sample of the fluid in the lump for microscopic analysis ,a procedure known as fine needle aspiration, or fine needle aspiration and cytology—FNAC to help establish the diagnosis. The needle aspiration may be performed in a healthcare provider's office or clinic using local anaesthetic if required. A finding of clear fluid makes the lump highly unlikely to be cancerous, but bloody fluid may be sent off for inspection under a microscope for cancerous cells. Together, physical examination of the breasts, mammography, and FNAC can be used to diagnose breast cancer with a good degree of accuracy.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 6: Treatments for breast cancer

Breast cancer treatment takes different approaches depending on the conditions. The mainstay of breast cancer treatment is surgery when the tumour is localized, followed by chemotherapy (when indicated), radiotherapy, and, for ER-positive tumours, adjuvant hormonal therapy (with tamoxifen or an aromatase inhibitor). Management of breast cancer is undertaken by a multidisciplinary team based on national and international guidelines. Depending on clinical criteria (age, type of cancer, size, presence or absence of metastasis) patients are roughly divided to high risk and low risk cases, with each risk category following different rules for therapy. Treatment possibilities include radiation therapy, chemotherapy, hormone therapy, and immune therapy.

Relevant conferences:

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 7: Chemotherapy

Neoadjuvant therapy is the administration of therapeutic agents before a main treatment. One example is neoadjuvant hormone therapy prior to radical therapy for adenocarcinoma   of the prostate. Adjuvant therapy or care, also called adjunct therapy or adjunctive therapy or care, is therapy that is given in addition to the primary, main, or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. Palliative care is a multidisciplinary approach to specialized medical care for people with serious illnesses. It focuses on providing patients with relief from the symptoms, pain, physical stress, and mental stress of a serious illness—whatever the diagnosis. The goal of such therapy is to improve quality of life for both the patient and the family. Palliative care is provided by a team of physicians, nurses, physiotherapists, occupational therapists and other health professionals who work together with the primary care physician and referred specialists (or, for patients who don't have those, hospital or hospital staff) to provide an extra layer of support.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 8: Breast cancer Surgery Choices

Most women with breast cancer have a kind of surgery. Surgery is often needed to discard a breast tumour. It includes breast conserving surgery and mastectomy (complete removal of breast). The breast can be reconstructed at the same time as surgery in progress and later on. Surgery is also used to find out the lymph nodes under the arm for cancer spread. It includes a sentinel lymph node biopsy when it has been affected to the lymphatic system and an axillary lymph node dissection. Mastectomy involves the removal of entire breast. When the lymph nodes have cancer cells, there might be a higher chance that cancer cells may spread through the bloodstream to vital parts of the body. Cancer cells in the lymph nodes under the arm is often an important criteria in deciding what treatment, in this case physicians prefer Lymph node surgery. Breast reconstructive therapy involves the restoration of the breast appearance after the surgery. Possible side effects may prone to manifest with women after breast cancer surgery.

Relevant conferences:

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 9: Innovative Therapeutic Approaches in Breast Cancer

Targeted Therapies is one of the innovative in breast cancer treatment. Several clinical trials led by physician-scientists at Mass General are revealing the power of new targeted anticancer therapies in breast cancer. Everolimus is a targeted therapy that works by zeroing in on the mTOR protein, which is regulated by the family of enzymes known as PI3 kinases (PI3K). In healthy cells, mTOR is involved in cell growth, cell proliferation, protein synthesis, and many other functions. Partial Breast  Irradiation many women who choose not to have a mastectomy instead undergo breast-conserving surgery where only the tumour and a small margin of tissue are removed, followed by a six-week course of daily radiation to the whole breast. Surgical Advances Two surgical advances available at Mass General are helping reduce complications and improve cosmetic appearance after breast cancer surgery. New trends to find breast cancer early, Determining the best ways for hormonal therapy, Anti- angiogenesis, Genetic risk and genetic testing (BRCA etc.), Finding new Reconstructive Surgery Approaches, Management of DCIS and ADH, Molecular Cancer Therapeutics, Targeted Therapies, Surgery for Breast Cancer.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 10: Clinical Trials -Breast Cancer

Phase 1 (phase I) trials study whether a new treatment is safe to use over a range of doses. The treatment may be given to people with different types of cancers.

A phase 1 trial is mainly a drug safety study.

Phase 2 (phase II) trials study how well a treatment works for a certain cancer, such as breast cancer. These trials may include between 25 and 100 people.

After a drug (or other therapy) is found to be effective in treating breast cancer in a phase 2 trial, a phase 3 trial will study it further.

Phase 3 (phase III) trials study how well a new treatment (including surgical procedures) works compared to the standard treatment (standard of care).

Phase 4 (phase IV) trials study the long-term side effects of treatments or answer new questions about the treatment.

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 11: Prevention Of Breast cancer

Surgical removal of both breasts is another preventative measure in some high risk women. In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy. Types of surgery vary from breast-conserving surgery to mastectomy Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort. The balance of benefits versus harms of breast cancer screening is controversial. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 12: Breast cancer during pregnancy

During pregnancy your breasts change in readiness for breast feeding. The breast tissue becomes more dense. This can make it more difficult to find changes in the breast that are due to cancer. The most common symptom of breast cancer is a lump. If you have a change that doesn’t go away after 2 to 4 weeks tell your doctor or midwife. Research shows that during pregnancy there is often a delay in diagnosis after women start to get breast symptoms. This is partly because breast cancer in pregnancy is so rare. It is also because the cancer can be difficult to diagnose because of the changes in the breast tissue. If the biopsy shows that you have cancer you may then have other tests to check the size of your cancer. Deciding which treatment to have and what that will mean for you and your developing baby can be very difficult. Doctors advise that your treatment should be as close as possible to what someone who isn’t pregnant would have. And whenever possible the treatment should not be delayed.

Relevant conferences:

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 13: Society and culture

Before the 20th century, breast cancer was feared and discussed in hushed tones, as if it were shameful. As little could be safely done with primitive surgical techniques, women tended to suffer silently rather than seeking care. When surgery advanced, and long-term survival rates improved, women began raising awareness of the disease and the possibility of successful treatment. A Pink Ribbon is the most prominent symbol of breast cancer awareness. Pink ribbons, which can be made inexpensively, are sometimes sold as fundraisers, much like poppies on Remembrance Day. They may be worn to honour those who have been diagnosed with breast cancer, or to identify products that the manufacturer would like to sell to consumers that are interested in breast cancer—usually white, middle-aged, middle-class and upper-class, educated women.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 14:Women’s health

Being a woman has a significant impact on health, as a result of both biological and gender-related disparities. The health of women and girls is of particular concern because, in many societies and communities, they are disadvantaged by discrimination in sociocultural factors. For example, women and girls face high vulnerability to HIV. Some of the difficulties faces by women these days includes-Hysterectomy is major surgery to remove your uterus or womb, menopause sometime between the ages of 45 and 55, but each woman will experience menopause differently, suffering from heavy, painful periods, vaginal problems at some stage. Whilst usually not serious, there are many different causes of vaginal problems including vaginal discharge, vaginal dryness, vaginal irritation and infection. Endometriosis -the tissue that lines the uterus is also found outside the uterine cavity, which can cause infertility.

Relevant conferences:

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 15: Women's   mental health

About 25% of people who die by suicide are women. Again, women’s greater emotional literacy and readiness to talk to others about their feelings and seek help may protect them from suicidal feelings. Being a mother also makes women less likely to take their own life .Women are more likely to have been treated for a Mental Health Problem than men (29% compared with 17%). This reflects women's greater willingness to acknowledge that they are troubled and get support. More women than men experience depression. However, some researchers dispute the relatively low depression rate for men. Post-natal depression is believed to affect between 8-15% of women after they have given birth.. Phobias affect about 22 in 1,000 women in the UK, compared with 13 in 1,000 men Two thirds of people with dementia are women. Risk of Dementia increases with age, and women have a higher life expectancy than men.

Relevant conferences: 

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13, 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

Track 16: Contraceptive technology and Pregnancy

Barrier contraceptives are devices that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide. Globally, condoms are the most common method of birth control Outlined here are the different types of barrier methods, spermicides, or coitus interrupts that must be used at before every act of intercourse. Immediate contraception, like physical barriers, include diaphragms, caps, the contraceptive sponge, and female condoms may be placed several hours before intercourse begins. The female condom should be removed immediately after intercourse, and before arising. Some other female barrier methods must be left in place for several hours after sex. Depending on the form of spermicide used, they may be applied several minutes to an hour before intercourse begins. Additionally, the male condom should be applied when the penis is erect so that it is properly applied prior to intercourse.

Relevant conferences:

2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 14th Annual Conference on Translational Medicine and Oncologists Meet, November 28-30, 2016, San Francisco, USA;  Advance in Medical & Surgical of Thyroid Cancer 2017 January 14–15 2017, Tampa , Florida , United States; 27th Annual  International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States;  ECCO European Cancer Congress 2017 January 27-30, 2017, Amsterdam , Netherlands; Practical Recommendation in  Immuno and Molecular Oncology Meeting  2017, February  9-12, 2017, Wailea-Makena , Hawall , United States;  Gynecologic Oncology Meeting  Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas ,United States Asian Society for Neuro-Oncology, Association for International Cancer Research, Association for the Study of Lung Cancer, Association of European Cancer Leagues, Association of European Cancer Leagues.

Track 17:  Menopause and its Management

Symptoms: Irregular periods, Lower fertility, Vaginal dryness, Hot flashes (UK term: hot flushes), Night sweats, Disturbed sleep, Urinary problems, Moodiness, More fat building up in the abdomen, Hair loss (thinning hair), Loss of breast size. Perimenopause is a natural stage of life. It is not a disease or a disorder. Therefore, it does not automatically require any kind of medical treatment. However, in those cases where the physical, mental, and emotional effects of perimenopause are strong enough that they significantly disrupt the life of the woman experiencing them, palliative medical therapy may sometimes be appropriate. The cultural context within which a woman lives can have a significant impact on the way she experiences the menopausal transition. Menopause has been described as a subjective experience, with social and cultural factors playing a prominent role in the way menopause is experienced and perceived.

Relevant conferences:

16th Global Annual Oncologists Meeting April 24-25, 2017, Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017, London, UK; 3rd International Conference on Urologic Oncology, June 26-28, 2017, Baltimore; 19th World Cancer Conference, Nov 21-23, 2017, London, UK; Frontiers in Cancer Immunotherapy, Feb 27–28 , 2017 New York City, US; 27–02 Mar 2017 ; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference Cancun, 27–02 Mar 2017  Mexico; Conference   Immune Regulation in Autoimmunity and Cancer, 26–30 Mar 2017, Whistler, Canada; Conference  Molecular Chaperones in Cancer, 02–04 May, 2017, Madrid, Spain; Oncologic Emergency Medicine 2017, January 12-13 2017, Houston , Texas , United States. American Cancer Society,  American Society for Radiation Oncology, Association of Cancer Online ResourcesAssociation of Cancer Physicians, American Society of Clinical Oncology

 

 

 

Market Analysis

Title: 4th World Congress on Breast Cancer and women's Health

Date &Venue: May 08-10, 2017 Holiday Inn Atrium, Singapore

 Theme: To Explore the Advances in Breast Cancer Research

Breast cancer and Women’s Health:

According to a new technical market research report, breast cancer diagnostic and drug technologies: global markets (HLC106A) from BCC Research the market for predictive diagnostic and drug technologies concerning breast cancer was valued at $21.2 billion in 2011. This figure is projected to reach nearly $24.1 billion in 2016, a five-year compound annual growth rate (CAGR) of 2.5%. The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019.

*Source: BCC Research

As per the market report most of the Oncology & Women’s Health companies mainly invests in the following:

  • Breast Cancer Diagnostic and Drug Technologies
  • Therapeutics for Women's Health
  • Cancer Vaccines
  • Biopsy Devices
  • Biological Therapies for Cancer Treatment

Breast Cancer Diagnostic and Drug Technologies:-

  • The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019.
  • Breast cancer drugs as a segment will grow from $10.2 billion in 2014 to nearly $13 billion by 2019 at a 5.0% CAGR for the period 2014-2019.
  • Quantitative immunofluorescence as a segment will grow from $6.5 billion in 2014 to $7.5 billion in 2019, increasing at a CAGR of 3.1% from 2014-2019.

Therapeutics for Women's Health:-

  • The global market for women’s health therapeutics will grow from nearly $33.0 billion in 2015 to nearly $40.6 billion by 2020, with a compound annual growth rate (CAGR) of 4.2% for the period of 2015-2020.
  • The U.S. dominated the women’s health therapeutics market and will grow from nearly $19.5 billion in 2015 to $25.3 billion by 2020, rising at a CAGR of 5.4%.
  • The European market is expected to increase from nearly $11.4 billion in 2015 to $13.0 billion by 2020 with a CAGR of 2.7%.
  • The global market for organ and tissue transplantation products and devices reached $56.9 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 7.1% to reach $64.4 billion by 2015 and nearly $90.6 billion by 2020.

Cancer Vaccines:-

  • The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019.
  • The United States as a segment will grow from about $1.9 billion in 2014 to $2 billion by 2019 at a 1.9% CAGR for the period 2014-2019.
  • Europe as a segment will grow from $1.0 billion in 2014 to $1.2 billion in 2019, increasing at a CAGR of 3.5% from 2014-2019.
  • The global market for solid organ preservation solutions totaled $459 million in 2014. This market is estimated to grow at a CAGR of 12.9% to reach $582.5 million by 2015 and nearly $1.1 billion by 2020.

Biopsy Devices:-

  • The global market for biopsy devices should reach around roughly $2.1 billion by 2020 from over $1.5 billion in 2015, a compound annual growth rate (CAGR) of 6.2% from 2015 to 2020.
  • The North American market should reach $868.8 million by 2020 from $663.9 million in 2015, at a CAGR of 5.5% from 2015 to 2020.
  • The European market should reach $785.3 million by 2020 from $586.0 million in 2015, at a CAGR of 6.0% from 2015 to 2020.
  • The global market for alternative technologies used in organ and tissue transplantation in 2014 totaled $30.5 billion. This market is estimated to grow at a CAGR of 4.6% from 2015 to 2020 to reach nearly $33.3 billion in 2015 and $41.6 billion by 2020.

Biological Therapies for Cancer Treatment:-

  • The global market for biologic cancer treatment totaled $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019.
  • Monoclonal antibodies as a segment will grow from around $28.5 billion in 2014 to about $37.3 billion by 2019 at a 5.6% CAGR for the period 2014-2019.
  • Immunostimulants as a segment will grow from $14.8 billion in 2014 to $18.5 billion in 2019, increasing at a CAGR of 4.6% from 2014-2019.

Breast cancer and Women’s Health Research Review:-

  • Breast cancer drug markets in the Asia-Pacific region look set to rise from 2014’s $1.9 billion figure to $3.4 billion by 2021, analysts predict. Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 research report says, thanks to an increasing uptake of branded drugs in Asia-Pacific (APAC), the region’s breast cancer therapeutics market value was $1.5 billion in 2013 and is estimated to reach $2.5 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 7.6%.
  • The global market for women’s health therapeutics will grow from nearly $33.0 billion in 2015 to nearly $40.6 billion by 2020, with a compound annual growth rate (CAGR) of 4.2% for the period of 2015-2020

Global breast cancer therapeutics market:-

Transparency Market Research forecasts that the global breast cancer therapeutics market is expected to be worth US$16.21 bn by 2023 as compared to US$7.17 bn in 2014, surging at a CAGR of 8.4% between 2015 and 2023. The drastically changing reproductive patterns are also responsible for soaring revenue earnings of the breast cancer therapeutics market. The delayed childbearing age, reduced breastfeeding periods, intake of oral contraceptives, and resorting to hormonal therapies to solve other medical conditions is also contributing towards the growth of this market.

*Source: Transparency Market Research

Cancer Vaccines: Technologies and Global Markets:

  • The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. Extensive promotion and marketing strategies and favourable government support are likely to boost market growth.
  • The global market for cancer vaccines was valued at nearly $4.2 billion and $4.0 billion in 2014 and 2015, respectively. This market is expected to decline from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a compound annual growth rate (CAGR) of -0.4% for 2016-2021.

Pharma Companies by oncology sales:-

The global oncology information system market is estimated to grow at a CAGR of 8.5% in the forecast period. Development of technologically advanced OIS, increasing prevalence of cancer, rapidly aging population, and increasing adoption of oncology information system are key factors fuelling growth of this market. As of 2013, Elekta AB (Sweden) and Varian Medical Systems, Inc. (U.S.) hold the leadership position in the global oncology information system market. Some of the other key players in this market are Accuray Incorporated (U.S.), Altos Solutions, Inc. (U.S.), Cerner Corporation (U.S.), Elekta AB (Sweden), Epic Systems Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), and McKesson Corporation (U.S.). Market players primarily focus on the development of innovative software solutions and inorganic strategies such as acquisitions and agreements in order to ensure their growth in this market.

  •       Roche
  •       Novartis        
  •       Celgene          
  •       Johnson & Johnson  
  •       Bristol-Myers Squibb          
  •       Lilly    
  •       Takeda          
  •       AstraZeneca  
  •       Merck & Co.
  •       Amgen                      
  •       Pfizer            

Target Audience:

  •      Academic Research Institutes
  •      Hospitals and Clinics
  •      Business Research and Consulting Service Providers
  •      Medical Research Laboratories
  •      Academic Medical Centres and Universities

       *Source: BCC Research; Transparent Market Research; Markets and Markets; MarketResearch.com

Past Conference Report

Breast Cancer 2016

 

Gratitude’s to all of our honourable speakers, conference attendees and sponsors. Breast Cancer 2016 Conference was our best ever!

3rd World Congress on Women’s Health and Breast Cancer conference, hosted by the Conference Series LLC was held during October 03-05, 2016 London, UK at Hilton London Heathrow Airport, UK with the theme “Pioneering Spirit of Enriching the Lives and Wellness of Women”. Magnanimous response and active participation was received from the Editorial Board Members of International Journals as well as from the Scientists, Doctors, Professors, oncologists, Radiologists, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the fields Women’s Health and Breast Cancer, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Breast Cancer- Present Perspective
  • Breast Cancer Surgery Choices
  • Breast Cancer Therapy
  • Breast cancer Rehabilitation/Survivorship
  • Breast Cancer- Clinical Trails
  • Women’s Mental Health
  • Gender based Violence

The conference was initiated with a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The list included:

  • Shahla Masood, University of Florida College of Medicine - Jacksonville, Florida, USA
  • Pier Luigi Santi, University of Genova, Italy
  • Michael Thompson, University of Toronto, Canada
  • Guan Chen, Medical College of Wisconsin, USA
  • Winnie Yeo, Prince of Wales Hospital- Chinese University of Hong Kong, Hong Kong
  • Linda deGraffenried, University of Texas at Austin, USA
  • Vasco Fonseca, Portuguese Institute of Oncology - Lisbon, Portugal
  • Pooja Saini, University of Liverpool, UK

With the grand success of Breast Cancer 2016, Conference Series LLC is proud to announce the “4th World Congress on Breast Cancer and Women’s Health” to be held during May 15-16, 2017 Singapore City, Singapore.

http://breastcancer.conferenceseries.com/asia-pacific


Past Reports  Proceedings  Gallery  

Breast Cancer Congress-2016

 

Thanks to all of our wonderful speakers, conference attendees and Sponsors, Breast Cancer Congress 2016 Conference was our best ever!

2nd World Congress on Breast Cancer, hosted by the Conference Series LLC was held during September 19-21, 2016 Phoenix, USA at Phoenix Airport Marriot, Phoenix, USA with the theme “New Discoveries for Better Diagnosis and Treatments for Breast Cancer and to bring Awareness”. Benevolent response and active participation was received from the Editorial Board Members of International Supporting Journals as well as from the Professors, Surgeons, Oncologists, Biostatisticians, Healthcare Professionals, Industry experts, Researchers and Students from the fields Breast Cancer Congress-2016, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Biology of Breast Cancer
  • Breast Cancer Tests: Screening, Diagnosis and Monitoring
  • HER2 Positive and Other Types of Breast Cancers
  • Breast Cancer Therapy
  • Chemotherapy for Breast Cancer
  • Breast Cancer Immunotherapy & Radiation Therapy
  • Innovative Therapeutic Approaches in Breast Cancer
  • Breast Cancer Treatment Side Effects
  • Optimal Breast Cancer Pathology – Organization

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list included:

  • Shahla Masood, University of Florida College of Medicine-Jacksonville, USA
  • Amila Orucevic, The University of Tennessee Medical Center, USA
  • Lei Huo, The University of Texas MD Anderson Cancer Center, USA
  • Colleen Huber, Naturopathic Oncology Research Institute, USA
  • Bolin Liu, University of Colorado Anschutz Medical Campus, USA
  • Bodour Salhia, University of Southern California, USA
  • Alexis Bousamra, Allegheny Health Network, USA
  • Muthusamy Thangaraju, Georgia Regents University, USA
  • Ashok Jain, Albany State University, USA
  • Hui Chen, The University of Texas MD Anderson Cancer Center, USA

With the grand success of Breast Cancer Congress-2016, Conference Series LLC is proud to announce the "5th World Congress on Breast Cancer” to be held during October 16-18, 2017 San Francisco, USA


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 08-10, 2017

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Day 1 Day 2 Day 3

Supported By

Breast Cancer: Current Research Journal of Cancer Science & Therapy Chemotherapy: Open Access Hereditary Genetics: Current Research

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

exhibitor

Exhibitor